Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-06-16-Speech-5-030"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20000616.3.5-030"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, Mr Turco’s report, which recommends that Parliament accepts the proposal for an agreement between the European Union and the Kingdom of Norway on the participation of Norway in the work of the European Monitoring Centre for Drugs and Drug Addiction, was discussed at length and then unanimously adopted by the Committee on Citizens’ Freedoms and Rights, Justice and Home Affairs. The amendments made by the Committee in agreement with the rapporteur, which have been incorporated into the proposal, are intended to exploit the opportunity presented by this agreement with Norway to give fresh impetus to the Centre’s work. The committee took into particular consideration the 1999 report on the Centre’s work and the difficulties encountered, and the outcome of the interinstitutional conference on drugs which took place in Brussels late last February. These sources showed that some of the constraints on the activities hitherto carried out by the Centre, which also restrict Union activity in this field, are caused by the wide range of differing information gathered by the various national centres linked to the Centre, with the result that it is difficult to draw conclusions from this information which would be useful in terms of prevention or damage limitation measures and operations to fight illegal trafficking.
The various amendments, including those dealing with the Centre’s Management Board, are therefore intended to ensure that the Board uses genuinely effective data-gathering methods which are capable of interpreting the data in the light of unit criteria and provide useful indications regarding the efficiency of the various national anti-drugs policies. Indeed, it appeared to many members of the Committee on Citizens’ Freedoms and Rights, Justice and Home Affairs that both the annual reports of the Centre and those tabled and adopted by Parliament fail to take into due account the analysis of the results obtained in the various countries, whose anti-drugs policies differ, moreover. The European Union needs to decide on its policies and recommendations to the governments of the Member States by means of a comprehensive assessment – which is not, as all too often happens, purely moralist – of the various strategies being followed in the various countries, especially with regard to prevention, damage limitation and consumer safety in the face of the constant emergence of new synthetic drugs.
We believe that the agreement on the participation of Norway in the work of the Centre, which, we hope, will pave the way for other enlargement initiatives, provides a major opportunity to revitalise the activity of this technical and scientific body, for the EMCDDA must become an increasingly important reference point in the development of a European policy to fight the illegal sale and distribution of drugs which are harmful to the health of the citizens of our countries."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples